학술논문
Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Document Type
Article
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 15 March 2014 88(4):793-800
Subject
Language
ISSN
0360-3016